DR. KEVIN J. SETTER, MD

EAST SYRACUSE, NY

Research Active
Orthopaedic Surgery - Hand Surgery NPI registered 21+ years 2 publications 1977 – 2020 NPI: 1740285584
RatsPostoperative ComplicationsKidneyEquipment DesignArthroplasty, Replacement, ShoulderShoulder JointOsteoarthritisGlomerular Filtration RateBone ScrewsPotassiumMicroscopy, ElectronGentamicinsProteinuriaShoulder ProsthesisBlood Urea Nitrogen

Practice Location

6620 FLY ROAD
EAST SYRACUSE, NY 13057

Phone: (315) 464-4472

What does KEVIN SETTER research?

Dr. Setter studies two main areas: shoulder prosthetics for patients with glenohumeral arthritis, which is a painful joint condition, and the effects of the antibiotic gentamicin on kidney health. In his work on shoulder implants, he examines the performance and safety of different prosthesis options, helping to improve quality of life for patients needing shoulder replacements. His research on gentamicin helps healthcare providers understand the potential kidney damage from this medication, allowing for safer use in medical treatments.

Key findings

  • In a study comparing the Eclipse and Univers II shoulder prostheses, the Eclipse had a 95% success rate compared to an 89.7% rate for the Univers II after two years.
  • Only 3.2% of patients with the Eclipse prosthesis needed further surgeries, indicating its effectiveness and safety.
  • In a study on gentamicin, high doses caused damage to kidney cells in rats, but kidney function remained mostly normal, suggesting the damage is reversible.

Frequently asked questions

Does Dr. Setter study shoulder arthritis?
Yes, he researches effective surgical options for treating shoulder arthritis.
What treatments has Dr. Setter researched?
He has studied shoulder prostheses for arthritis and the effects of the antibiotic gentamicin on kidneys.
Is Dr. Setter's work relevant to patients using gentamicin?
Yes, his research helps doctors manage gentamicin use to minimize potential kidney damage.

Publications in plain English

Eclipse stemless shoulder prosthesis vs. Univers II shoulder prosthesis: a multicenter, prospective randomized controlled trial.

2020

Journal of shoulder and elbow surgery

Romeo AA, Erickson BJ, Costouros J, Long N, Klassen J +14 more

Plain English
This study compared two types of shoulder prostheses—Eclipse and Univers II—in patients with severe shoulder arthritis who did not improve with other treatments. Researchers found that the Eclipse prosthesis had a success rate of 95% after two years, while the Univers II had a success rate of 89.7%. Both implants were shown to be safe, with similar rates of reoperations (3.2% for Eclipse and 3.8% for Univers II), meaning the Eclipse prosthesis is a good option for these patients. Who this helps: This benefits patients with severe shoulder arthritis looking for effective treatment options.

PubMed

Gentamicin nephrotoxicity. II. Physiological, biochemical and morphological effects of prolonged administration to rats.

1977

Virchows Archiv. B, Cell pathology

Cuppage FE, Setter K, Sullivan P, Reitzes EJ, Melnykovych AO

Plain English
This study looked at the effects of the antibiotic gentamicin on the kidneys of rats when given at different doses over 28 days. The researchers found that high doses (40 mg per kg per day) caused damage to certain kidney cells and affected how the kidney processed substances, although the overall kidney function remained mostly normal. This is important because it shows that while gentamicin can harm kidney cells at high doses, the damage seems reversible and highlights the need for careful dosing in human patients who typically receive much lower amounts. Who this helps: This helps doctors and healthcare providers manage gentamicin usage in patients.

PubMed

Frequent Co-Authors

Anthony A Romeo Brandon J Erickson John Costouros Nathan Long Jeffrey Klassen Arash Araghi John Brown Joshua Port William Tyndall Nikhil N Verma

Physician data sourced from the NPPES NPI Registry . Publication data from PubMed . Plain-English summaries generated by AI. Not medical advice.